Cognis Group is an international Life Sciences consultancy specializing in future-proofing company technology innovation pipelines. We are the convergence of businesses spanning three decades of experience in Intellectual Property and Strategic Partnering—now distinctively combined with Future Trends. Our unique methodology, called Current Futures, combines current IP, landscaping, and subject matter research with macro trend foresight to validate where tech innovation life cycles will peak and plateau over the next two decades. This combination dramatically enhances the intelligence validation to inform decisions around innovation potential. Companies and investors alike leverage this proprietary methodology combined with our global network of partnering connections to get to faster, smarter commercialization of billion-dollar market opportunities. Cognis offers broad access to experts across an expansive number of science & technology industries, making us a full-service partner for clients ranging from Fortune 500 companies, to research universities and federal institutions, to individual inventors. In addition to our custom consulting services, Cognis provides curated self-service resource sites for clients: Pharmalicensing.com allows free exploration of the largest selection of commercially available life science opportunities from the pharmaceutical and medical device industries—with a user base spanning 110 countries. Futureinfocus.com provides concise, intelligent research reports around the future of consumers, markets, and technologies across expansive industries and around the globe. Please Connect with Us: Info@cognisgroup.com US 8139718273 UK ‭+44 1904 435190‬